Apr 07, 2012, 02.29 PM IST

Consumers sector results preview for Q4FY12: Emkay

Emkay Global Financial Services has come with its March quarterly earning estimates for consumers sector. The research firm has recommended to buy Nestle, GSK Consumer and Marico from agri-input dependant companies and categories.

Source: Moneycontrol.com
Share Share on Tumblr
Share  .  Email  .  Print  .  A+
Emkay Global Financial Services has come with its March quarterly earning estimates for consumers sector. The research firm has recommended to buy Nestle , GSK Consumer and Marico from agri-input dependant companies and categories.


• Q4FY12E is expected to gain from price increases implemented in recent months. Consequently, revenue expected to grow 22% yoy to Rs175.7 bn – a lot driven by price increase (implemented in recent months) and NO improvement in volume growth momentum on qoq basis.


• Emkay pegs the volume-led growth at 9-10% yoy and balance driven by price increases. Also, non-discretionary continues to remain stronger then discretionary categories. Emkay expectation for volume growth - Titan (-7%) in Jewellery, Asian Paints (+10%), Berger (+10%), HUL (+9%), Colgate (+13%), Nestle (+7%), GSK Consumer (+11%) and Marico (+12%).


• Also, Q4FY12E reverses the price-trailing-cost inflation – gaining from correction in soft commodities and benefits from price increases alongside favorable base effects in select few companies. Emkay expects Core Ebidta margins to expand  64 bps yoy, but contract 47 bps on qoq basis - Asian Paints (74 bps), Berger Paints (72 bps), HUL (134 bps), Marico (295 bps) and Titan (243 bps).


• Favorable base effect (Asian Paints, Berger Paints, HUL, Marico, Titan) alongside expansion of Core Ebidta margins - Ebidta growth forecasted at 28% yoy to Rs26.2 bn and APAT growth at 25% yoy to Rs18.2 bn. In EMKAY universe - Weakest performance for Colgate (-4%), GSK Consumer (3%) and Best performance for Marico (3X and HUL (29%).


• With rural markets expected to stutter (refer ‘Rural Steroids Ebbing’) and urban markets already reporting moderation in growth momentum, risks to sustained volume growth has increased. Further, one-year forward valuations for our coverage universe remain at relatively higher valuations leaving little room for negative surprise.


• Themes to play consumer sector (1) avoid rural centric categories and companies – Avoid HUL and Colgate (2) avoid discretionary categories – Avoid Asian Paints & Titan Paints (3) play agri-input dependant companies and categories – Buy Nestle, GSK Consumer and Marico (4) company specific triggers – Buy Berger Paints.


Company Name


Net Sales (Rs mn)


APAT (Rs mn)


Q4FY12


Q3FY12


Q4FY11


Q4FY12


Q3FY12


Q4FY11


Asian Paints


23224


25605


19656


2204


2569


1860


Berger Paints


7005


7814


5871


386


491


339


Colgate Palmolive


6995


6696


5818


1097


1156


1141


Glaxosmithkline Consumer


8378


6021


7100


1138


591


1106


Godrej Consumer Products


14975


13509


10069


1667


1833


1417


Hindustan Unilever


58156


59376


49666


6245


7662


4855


Jubilant FoodWorks


2807


2770


1936


299


303


193


Marico


9546


10578


7473


847


841


210


Nestle


21502


19547


18100


2848


2681


2626


Titan Industries


23145


24401


17775


1464


1636


809



 


 


 


 


 


 


 


 


 


 


 


 


 


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.


Set email alert for

Action in Nestle India
HTC One up for pre-order for Rs 42,900, shipping to begin next week
Nine years of UPA: What makes Sonia Gandhi the real hero "Nine years of UPA: What makes Sonia Gandhi the real hero"

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

May 23 2013, 16:33

Japan`s fall natural after 80% rally in 6 months: AMP Cap

- in Asian markets